INDV.L

Indivior Plc
Indivior PLC - Transaction in Own Shares
24th December 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 1731R
Indivior PLC
24 December 2024
 

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

December 24, 2024

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 209,246 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from December 16, 2024, up to and including December 20, 2024, in connection with its $100m Share Repurchase Program. Aggregated information on the purchase of these shares can be found in the table below.

Following the purchase and cancellation of the above shares (including those purchased but not yet settled), Indivior has 125,062,916 ordinary shares of $0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (125,062,916) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Indivior under the FCA's Disclosure Guidance and Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and "on market" for the purposes of the Companies Act 2006.

Aggregated information

Trading Date

Trading Venue

Aggregated daily volume (number of shares)

Daily weighted average purchase price of the shares (p)

16/12/2024

LSE

16,243

920.78

16/12/2024

BATE

6,034

919.89

16/12/2024

CHIX

16,371

919.54

16/12/2024

AQUIS

3,123

916.77

17/12/2024

LSE

25,718

931.58

17/12/2024

BATE

5,231

931.09

17/12/2024

CHIX

16,759

930.15

17/12/2024

AQUIS

821

926.66

18/12/2024

LSE

14,770

942.76

18/12/2024

BATE

6,911

941.62

18/12/2024

CHIX

15,222

942.22

18/12/2024

AQUIS

2,465

942.17

19/12/2024

LSE

16,217

910.35

19/12/2024

BATE

4,669

908.69

19/12/2024

CHIX

16,156

911.69

19/12/2024

AQUIS

1,697

912.18

20/12/2024

LSE

16,317

912.01

20/12/2024

BATE

6,705

908.38

20/12/2024

CHIX

14,161

908.16

20/12/2024

AQUIS

3,656

918.09

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation (EU) No 596/2014, as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU) 2016/1052, a full breakdown of the individual purchases of ordinary shares made by Morgan Stanley & Co. International Plc on behalf of Indivior during the above period as part of the Share Repurchase Program can be found at www.indivior.com/en/investors/shareholder-information/share-repurchase-program.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFZMZZKFGGDZM]]>
TwitterFacebookLinkedIn